Nursing, Sleeping Disorders
Conditions
Brief summary
With aging, deterioration in sleep structure and balance occurs. In particular, individuals over the age of 65 often have sleep problems, and non-pharmacological methods used to solve this problem are much more reliable than pharmacological methods. It is important for nurses who contribute most to their care to regulate and facilitate sleep, which is one of the basic needs of people. Thanks to this study, it is planned to solve the sleep-related problems of elderly individuals by using the sedative and relaxing effect of the lavender plant, which is used in many areas, thus increasing their quality of life, and it is planned to prevent falls by increasing their physical balance controls. This study aims to determine the effect of lavender scent recommended for the elderly in Konya on sleep quality and physical balance. This research is a randomized experimental design with pretest-posttest control group. The research is planned to be carried out between January 2023 and November 2023. The population of the research consists of elderly individuals living in society. In order to determine the sample size, power analysis will be made using the G-Power (v3.1.9.2) program. Personal Information Form and Pittsburgh Sleep Quality Index will be used in data collection. The data obtained as a result of the research; It will be analyzed with IBM SPSS program. p\<0.05 will be considered statistically significant.
Detailed description
The research data is planned to be collected between January 2023 and November 2023. Data will be collected from elderly individuals from the community. After the elderly individuals who meet the appropriate criteria are informed about the research, their verbal and written consent will be obtained that they agree to participate in the research. Experimental Group In order to collect the pre-test data of the experimental group, individuals who accept the study will be asked to fill in the Personal Information Form, Sleep Quality Scale and Berg Balance Scale. The forms will be collected after the individuals mark the options closest to them on the forms. It is planned to last approximately 25-30 minutes. It is planned to recommend lavender scent as a nursing intervention to improve sleep quality in individuals with irregular sleep and low sleep quality. Participants in the experimental group will be informed about the effects of lavender scent on sleep and will be given lavender pouches. They will be informed that they should put these lavender pouches in their pillows where they sleep every day and that they should sleep with the lavender pouch for the next month, and that they should not make any changes in their rooms or beds other than the lavender pouch. After the one-month lavender scent application of the experimental group is completed, the post-test data will be collected for the experimental group. After the individuals who gave the closest answer to themselves completed the forms, the post-test data will be collected and the data collection phase of the research will be completed. Control Group The study will start by collecting the pre-test data of the control group. Individuals who agree to participate in the study will be asked to fill in the Personal Information Form, Sleep Quality Scale and Berg Balance Scale to collect pre-test data. The forms will be collected after the individuals mark the options closest to them on the forms. After collecting the pre-test data, no intervention will be made to the participants for one month. At the end of one month, the control group will be administered the post-test with the same data collection tools.
Interventions
Participants in the experimental group will be informed about the effects of lavender scent on sleep and lavender sachets will be given. They will be informed that they should put these lavender sachets in their pillows every day and sleep with a lavender sachet for the next month, and that they should not make any changes in their rooms or beds other than the lavender sachet.
Sponsors
Study design
Eligibility
Inclusion criteria
* Volunteer to participate in the study. * Working in shifts for at least three months * Individuals who do not have a disease that would prevent research and communication will be included in the research.
Exclusion criteria
* Lavender allergy * Patients with asthma, bronchitis * Use of drug(s) that induce sleep * Individuals who have received a medical diagnosis for attention will not be included in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pittsburgh Sleep Quality İndex (PSQI) | Pretest (measurement taken during the initial encounter) | The total score has a value between 0-21, a high total score indicates poor sleep quality. A total PSQI score of less than 5 indicates the good sleep quality and a score of more than 5 indicates the poor sleep quality |
| Berg Balance Scala (BBS) | Pretest (measurement taken during the initial encounter) | Items include daily activities such as static sitting and standing balance, as well as transferring, turning, picking up objects, etc. Each item is rated on a scale of 0 to 4. The maximum total score is 56. A high score indicates good balance. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pittsburgh Sleep Quality İndex (PSQI) | Posttest (measurement one month after the pre-test) | The total score has a value between 0-21, a high total score indicates poor sleep quality. A total PSQI score of less than 5 indicates the good sleep quality and a score of more than 5 indicates the poor sleep quality. |
| Berg Balance Scala (BBS) | Posttest (measurement one month after the pre-test) | Items include daily activities such as static sitting and standing balance, as well as transferring, turning, picking up objects, etc. Each item is rated on a scale of 0 to 4. The maximum total score is 56. A high score indicates good balance. |
Countries
Turkey (Türkiye)
Contacts
KTO Karatay University
Participant flow
Recruitment details
complementary medicine
Pre-assignment details
Refused to participate (n=18) Did not fulfil the inclusion criteria (n=12)
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 90 Participants |
| Age, Categorical Between 18 and 65 years | 0 Participants |
| Age, Continuous | 74.60 years STANDARD_DEVIATION 7.18 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 90 Participants |
| Race (NIH/OMB) White | 0 Participants |
| Region of Enrollment Turkey | 45 participants |
| Sex: Female, Male Female | 27 Participants |
| Sex: Female, Male Male | 24 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |